Plasma HSPA12B is a potential predictor for poor outcome in severe sepsis

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Zhang, Ran ^a   Wan, Xiao Jian ^a   Zhang, Xu ^a   Kang, Qiu Xiang ^a   Bian, Jin Jun ^a   Yu, Gui Fang ^b   Wang, Jiafeng ^a   Zhu, Ke Ming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 12B; INTERLEUKIN 10; INTERLEUKIN 6; UNCLASSIFIED DRUG; HSPA12B PROTEIN, HUMAN; HSPA12B PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PREDICTIVE VALUE; PREDICTOR VARIABLE; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEPSIS; SURVIVAL PREDICTION; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; BLOOD; C57BL MOUSE; CECUM; DEMOGRAPHY; EXTRACELLULAR SPACE; LIGATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PUNCTURE; SURVIVOR; TIME; TREATMENT OUTCOME;

ADULT; ANIMALS; CECUM; DEMOGRAPHY; EXTRACELLULAR SPACE; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LIGATION; MALE; MICE, INBRED C57BL; MIDDLE AGED; PROGNOSIS; PUNCTURES; ROC CURVE; SEPSIS; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84903641545     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101215     Document Type: Article

References (38)

1. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554.
2. Brun-Buisson C, Meshaka P, Pinton P, Vallet B, EPISEPSIS Study Group (2004) EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30: 580-588.
3. Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, et al. (2007) Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33: 606-618.
4. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, et al. (1997) Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278: 234-240.
5. Harrison DA, Welch CA, Eddleston JM (2006) The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care 10:R42.
6. Seymour CW, Iwashyna TJ, Cooke CR, Hough CL, Martin GS (2010) Marital status and the epidemiology and outcomes of sepsis. Chest 137: 1289-1296.
7. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368-1377.
8. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, et al. (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Crit Care Med 41: 580-637.
9. Jacob ST, Banura P, Baeten JM, Moore CC, Meya D, et al. (2012) The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: a prospective intervention study*. Crit Care Med 40: 2050-2058.
10. Rivers EP, Jaehne AK, Nguyen HB, Papamatheakis DG, Singer D, et al. (2013) Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: not a time to give up, but to give it earlier. Shock 39: 127-137.
11. Gibot S, Béné MC, Noel R, Massin F, Guy J, et al. (2012) Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med 186: 65-71.
12. Ware LB, Eisner MD, Thompson BT, Parsons PE, Matthay MA (2004) Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 170: 766-772.
13. Skibsted S, Jones AE, Puskarich MA, Arnold R, Sherwin R, et al. (2013) Biomarkers of Endothelial Cell Activation in Early Sepsis. Shock 39: 427-432.
14. Ricciuto DR, dos Santos CC, Hawkes M, Toltl LJ, Conroy AL, et al. (2011) Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med 39: 702-710.
15. Aird WC (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101: 3765-3777.
16. Guitton C, Gérard N, Sébille V, Bretonnière C, Zambon O, et al. (2011) Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsis. Intensive Care Med 37: 950-956.
17. Han Z, Truong QA, Park S, Breslow JL (2003) Two Hsp70 family members expressed in atherosclerotic lesions. Proc Natl Acad Sci U S A 100: 1256-1261.
18. Hu G, Tang J, Zhang B, Lin Y, Hanai J, et al. (2006) A novel endothelial-specific heat shock protein HspA12B is required in both zebrafish development and endothelial functions in vitro. J Cell Sci 119: 4117-4126.
19. Zhou H, Qian J, Li C, Li J, Zhang X, et al. (2011) Attenuation of cardiac dysfunction by HSPA12B in endotoxin-induced sepsis in mice through a PI3K-dependent mechanism. Cardiovasc Res 89: 109-118.
20. Ma Y, Lu C, Li C, Li R, Zhang Y, et al. (2013) Overexpression of HSPA12B protects against cerebral ischemia/reperfusion injury via a PI3K/Akt-dependent mechanism. Biochim Biophys Acta 1832: 57-66.
21. Yeh CH, Tseng R, Zhang Z, Cortes J, O'Brien S, et al. (2009) Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia. Leuk Res 33: 212-217.
22. Ogawa K, Kim HK, Shimizu T, Abe S, Shiga Y, et al. (2012) Plasma heat shock protein 72 as a biomarker of sarcopenia in elderly people. Cell Stress Chaperones 17: 349-359.
23. Zhu J, Wang J, Sheng Y, Zou Y, Bo L, et al. (2012) Baicalin improves survival in a murine model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte apoptosis. PLoS One 2012;7:e35523.
24. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. (2003) International Sepsis Definitions Conference: 2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250-1256.
25. Manley MO, O'Riordan MA, Levine AD, Latifi SQ (2005) Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome. Shock 23: 521-526.
26. Cheng B, Xie G, Yao S, Wu X, Guo Q, et al. (2007) Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit Care Med 35: 2538-2546.
27. Lefrant JY, Muller L, Raillard A, Jung B, Beaudroit L, et al. (2010) Reduction of the severe sepsis or septic shock associated mortality by reinforcement of the recommendations bundle: a multicenter study. Ann Fr Anesth Reanim 29: 621-628.
28. Suarez D, Ferrer R, Artigas A, Azkarate I, Garnacho-Montero J, et al. (2011) Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis: a prospective nation-wide study in Spain. Intensive Care Med 37: 444-452.
29. Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, et al. (2012) Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis 12: 919-924.
30. Cardoso T, Carneiro AH, Ribeiro O, Teixeira-Pinto A, Costa-Pereira A (2010) Reducing mortality in severe sepsis with the implementation of a core 6-hour bundle: results from the Portuguese community-acquired sepsis study (SACiUCI study). Crit Care 14:R83.
31. Wang JF, Yu ML, Yu G, Bian JJ, Deng XM, et al. (2010) Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun 394: 184-188.
32. Gouel-Chéron A, Allaouchiche B, Guignant C, Davin F, Floccard B, et al. (2012) Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PLoS One 7:e33095.
33. Heper Y, Akalin EH, Mistik R, Akgöz S, Töre O, et al. (2006) Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 25: 481-491.
34. Miguel-Bayarri V, Casanoves-Laparra EB, Pallás-Beneyto L, Sancho-Chinesta S, Martín-Osorio LF, et al. (2012) Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis. Med Intensiva 36: 556-562.
35. Rose WE, Eickhoff JC, Shukla SK, Pantrangi M, Rooijakkers S, et al. (2012) Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia. J Infect Dis 206: 1604-1611.
36. Walkey AJ, Wiener RS, Ghobrial JM, Curtis LH, Benjamin EJ (2011) Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA 306: 2248-2254.
37. Walkey AJ, Greiner MA, Heckbert SR, Jensen PN, Piccini JP, et al. (2013) Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors. Am Heart J 165: 949-955.
38. Wang HE, Shapiro NI, Griffin R, Safford MM, Judd S, et al. (2012) Chronic medical conditions and risk of sepsis. PLoS One 7:e48307.